Global Pets Internal Parasiticide Market Research Report 2024

Publication ID:

PB503248328

Publication Date:

March 18, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Pets internal parasiticides are medications or treatments used to control and eliminate internal parasites in dogs, cats, and other household pets. Internal parasites, such as worms (helminths) and protozoa, can infest the gastrointestinal tract or other internal organs of pets, leading to health issues, discomfort, and potential transmission to humans. Internal parasiticides help manage and control these parasites, improving the health and well-being of pets.
The global Pets Internal Parasiticide market was valued at US$ 2658 million in 2023 and is anticipated to reach US$ 4076.8 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
Some internal parasiticides for pets are broad-spectrum treatments that target multiple types of internal parasites. These medications may include a combination of anthelmintics and/or other active ingredients effective against worms, protozoa, and other parasites.It is important to follow veterinary guidance, adhere to dosing instructions, and consult with a veterinarian for proper diagnosis and treatment recommendations for pets. Regular preventive measures include deworming medications, appropriate hygiene practices, regular veterinarian check-ups, and testing to ensure the well-being and health of pets. Responsible pet ownership, including routine veterinary care and maintaining a clean living environment, can also help prevent and control internal parasite infestations.
This report aims to provide a comprehensive presentation of the global market for Pets Internal Parasiticide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets Internal Parasiticide.
Report Scope
The Pets Internal Parasiticide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pets Internal Parasiticide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pets Internal Parasiticide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Chanelle
Segment by Type
Tablet
Powder
Segment by Application
Dogs
Cats
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pets Internal Parasiticide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pets Internal Parasiticide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pets Internal Parasiticide Market Overview
1.1 Product Overview and Scope of Pets Internal Parasiticide
1.2 Pets Internal Parasiticide Segment by Type
1.2.1 Global Pets Internal Parasiticide Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Powder
1.3 Pets Internal Parasiticide Segment by Application
1.3.1 Global Pets Internal Parasiticide Market Value by Application: (2024-2030)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Global Pets Internal Parasiticide Market Size Estimates and Forecasts
1.4.1 Global Pets Internal Parasiticide Revenue 2019-2030
1.4.2 Global Pets Internal Parasiticide Sales 2019-2030
1.4.3 Global Pets Internal Parasiticide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pets Internal Parasiticide Market Competition by Manufacturers
2.1 Global Pets Internal Parasiticide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pets Internal Parasiticide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pets Internal Parasiticide Average Price by Manufacturers (2019-2024)
2.4 Global Pets Internal Parasiticide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pets Internal Parasiticide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pets Internal Parasiticide, Product Type & Application
2.7 Pets Internal Parasiticide Market Competitive Situation and Trends
2.7.1 Pets Internal Parasiticide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pets Internal Parasiticide Players Market Share by Revenue
2.7.3 Global Pets Internal Parasiticide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pets Internal Parasiticide Retrospective Market Scenario by Region
3.1 Global Pets Internal Parasiticide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pets Internal Parasiticide Global Pets Internal Parasiticide Sales by Region: 2019-2030
3.2.1 Global Pets Internal Parasiticide Sales by Region: 2019-2024
3.2.2 Global Pets Internal Parasiticide Sales by Region: 2025-2030
3.3 Global Pets Internal Parasiticide Global Pets Internal Parasiticide Revenue by Region: 2019-2030
3.3.1 Global Pets Internal Parasiticide Revenue by Region: 2019-2024
3.3.2 Global Pets Internal Parasiticide Revenue by Region: 2025-2030
3.4 North America Pets Internal Parasiticide Market Facts & Figures by Country
3.4.1 North America Pets Internal Parasiticide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pets Internal Parasiticide Sales by Country (2019-2030)
3.4.3 North America Pets Internal Parasiticide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pets Internal Parasiticide Market Facts & Figures by Country
3.5.1 Europe Pets Internal Parasiticide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pets Internal Parasiticide Sales by Country (2019-2030)
3.5.3 Europe Pets Internal Parasiticide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pets Internal Parasiticide Market Facts & Figures by Country
3.6.1 Asia Pacific Pets Internal Parasiticide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pets Internal Parasiticide Sales by Country (2019-2030)
3.6.3 Asia Pacific Pets Internal Parasiticide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pets Internal Parasiticide Market Facts & Figures by Country
3.7.1 Latin America Pets Internal Parasiticide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pets Internal Parasiticide Sales by Country (2019-2030)
3.7.3 Latin America Pets Internal Parasiticide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pets Internal Parasiticide Market Facts & Figures by Country
3.8.1 Middle East and Africa Pets Internal Parasiticide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pets Internal Parasiticide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pets Internal Parasiticide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pets Internal Parasiticide Sales by Type (2019-2030)
4.1.1 Global Pets Internal Parasiticide Sales by Type (2019-2024)
4.1.2 Global Pets Internal Parasiticide Sales by Type (2025-2030)
4.1.3 Global Pets Internal Parasiticide Sales Market Share by Type (2019-2030)
4.2 Global Pets Internal Parasiticide Revenue by Type (2019-2030)
4.2.1 Global Pets Internal Parasiticide Revenue by Type (2019-2024)
4.2.2 Global Pets Internal Parasiticide Revenue by Type (2025-2030)
4.2.3 Global Pets Internal Parasiticide Revenue Market Share by Type (2019-2030)
4.3 Global Pets Internal Parasiticide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pets Internal Parasiticide Sales by Application (2019-2030)
5.1.1 Global Pets Internal Parasiticide Sales by Application (2019-2024)
5.1.2 Global Pets Internal Parasiticide Sales by Application (2025-2030)
5.1.3 Global Pets Internal Parasiticide Sales Market Share by Application (2019-2030)
5.2 Global Pets Internal Parasiticide Revenue by Application (2019-2030)
5.2.1 Global Pets Internal Parasiticide Revenue by Application (2019-2024)
5.2.2 Global Pets Internal Parasiticide Revenue by Application (2025-2030)
5.2.3 Global Pets Internal Parasiticide Revenue Market Share by Application (2019-2030)
5.3 Global Pets Internal Parasiticide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Pets Internal Parasiticide Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Pets Internal Parasiticide Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Pets Internal Parasiticide Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Pets Internal Parasiticide Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Pets Internal Parasiticide Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Virbac Pets Internal Parasiticide Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Ceva Sante Animale
6.6.1 Ceva Sante Animale Corporation Information
6.6.2 Ceva Sante Animale Description and Business Overview
6.6.3 Ceva Sante Animale Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Sante Animale Pets Internal Parasiticide Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vetoquinol Pets Internal Parasiticide Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Bimeda Animal Health
6.9.1 Bimeda Animal Health Corporation Information
6.9.2 Bimeda Animal Health Description and Business Overview
6.9.3 Bimeda Animal Health Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bimeda Animal Health Pets Internal Parasiticide Product Portfolio
6.9.5 Bimeda Animal Health Recent Developments/Updates
6.10 Chanelle
6.10.1 Chanelle Corporation Information
6.10.2 Chanelle Description and Business Overview
6.10.3 Chanelle Pets Internal Parasiticide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chanelle Pets Internal Parasiticide Product Portfolio
6.10.5 Chanelle Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pets Internal Parasiticide Industry Chain Analysis
7.2 Pets Internal Parasiticide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pets Internal Parasiticide Production Mode & Process
7.4 Pets Internal Parasiticide Sales and Marketing
7.4.1 Pets Internal Parasiticide Sales Channels
7.4.2 Pets Internal Parasiticide Distributors
7.5 Pets Internal Parasiticide Customers
8 Pets Internal Parasiticide Market Dynamics
8.1 Pets Internal Parasiticide Industry Trends
8.2 Pets Internal Parasiticide Market Drivers
8.3 Pets Internal Parasiticide Market Challenges
8.4 Pets Internal Parasiticide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Chanelle

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂